(Q74212005)
Statements
A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis (English)
Knowles MR
Noone PG
Hohneker K
Johnson LG
Boucher RC
Efthimiou J
Crawford C
Brown R
Schwartzbach C